Bradford Goodwin Insider Profile
4 Followers
Bradford Goodwin, Director at Rigel, holds 35.00K shares in Rigel (Ticker: RIGL), holds 0.00 shares in PDL BioPharma (Ticker: PDLI), holds 367.18K shares in Paratek Pharmaceuticals (Ticker: PRTK).
Bradford Goodwin's Trading History
| RIGLRigel | May 21, 2021 | Director | Uninformative Buy | ― | $1.53M | |
| NGSXNeurogesx | Feb 01, 2012 | ― | Uninformative Buy | 20.20K | $475.00 | |
| PRTKParatek Pharmaceuticals | ― | ― | ― | $818.81K | ||
| PDLIPDL BioPharma | ― | ― | ― | $0.00 |
You May Also Like
Bradford Goodwin insider profile FAQ
What is the percentage of profitable transactions made by Bradford Goodwin?
The percentage of profitable transactions made by Bradford Goodwin is 0%.
What is the average return per transaction made by Bradford Goodwin?
The average return per transaction made by Bradford Goodwin is -69.00%.
What stocks does Bradford Goodwin hold?
Bradford Goodwin holds: RIGL, PDLI, PRTK, NGSX stocks.
What was Bradford Goodwin's most profitable transaction?
Bradford Goodwin’s most profitable transaction was an Informative Buy of NGSX stock on August 11, 2010. The return on the trade was -65.60%.
What is Bradford Goodwin's role in Rigel?
Bradford Goodwin's role in Rigel is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
